Fig. 1 · Structure
Documents & Downloads
Taldefgrobep alfa
Myostatin Inhibitor
Taldefgrobep alfa is a potent myostatin inhibitor designed to enhance muscle growth by targeting human myostatin. This fusion protein consists of a human IgG1-Fc domain linked to an Adnectin domain, facilitating its mechanism of action. Taldefgrobep alfa is particularly useful in research applications focused on spinal muscular atrophy (SMA) and other muscle-wasting conditions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1580555-26-5 |
| Applications | Myostatin Inhibitor |
| Molecular Weight | 75.59 kDa |
| Synonyms | BMS 986089; RG 6206; RO 7239361; BHV2000 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.